Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine whether combined treatment with liraglutide and
metformin is more effective than liraglutide or metformin as monotherapy in the treatment of
obese women with polycystic ovary syndrome (PCOS) who had been previously poor responders
regarding weight reduction on metformin monotherapy. We anticipated greater changes in body
weight in patients on combined treatment than in those on monotherapy with liraglutide or
metformin.